Aviragen Therapeutics, created in 1969 (Australia), from
2214 competing brands.
Aviragen Therapeutics is owned by VAXART INC, listed on the stock exchange of New York
Aviragen Therapeutics is part of the Biotechnology activity sector.
Aviragen Therapeutics is a brand of VAXART INC (VXRT) Share price
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.